Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, August 1999, p. 2090-2092, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
In Vitro Susceptibilities of Four Bartonella
bacilliformis Strains to 30 Antibiotic Compounds
Mireille
Sobraquès,
Max
Maurin,
Richard J.
Birtles, and
Didier
Raoult*
Unité des Rickettsies, CNRS UPRES A
6020, Faculté de Médecine, Université de la
Méditerranée, 13385 Marseille Cedex 05, France
Received 22 April 1999/Accepted 28 May 1999
We have evaluated for the first time in vitro antibiotic
susceptibilities of four human strains of Bartonella
bacilliformis, the agent of Carrion's disease. Our results show
that B. bacilliformis, like other Bartonella
species, is highly susceptible to antibiotics, including most
beta-lactams, aminoglycosides, chloramphenicol, rifampin, macrolides,
tetracyclines, cotrimoxazole, and fluoroquinolones.
*
Corresponding author. Mailing address: Unité des
Rickettsies, CNRS UPRES A 6020, Faculté de Médecine,
Université de la Méditerranée, 27 Boulevard Jean
Moulin, 13385 Marseille Cedex 05, France. Phone: (33) 4 91 38 55 17. Fax: (33) 4 91 83 03 90. E-mail:
Didier.Raoult{at}medecine.univ-mrs.fr.
Antimicrobial Agents and Chemotherapy, August 1999, p. 2090-2092, Vol. 43, No. 8
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dorbecker, C., Sander, A., Oberle, K., Schulin-Casonato, T.
(2006). In vitro susceptibility of Bartonella species to 17 antimicrobial compounds: comparison of Etest and agar dilution. J Antimicrob Chemother
58: 784-788
[Abstract]
[Full Text]
-
HENRIQUEZ, C., HINOJOSA, J. C., VENTOSILLA, P., INFANTE, B., MERELLO, J., MALLQUI, V., VERASTEGUI, M., MAGUINA, C.
(2004). REPORT OF AN UNUSUAL CASE OF PERSISTENT BACTEREMIA BY BARTONELLA BACILLIFORMIS IN A SPLENECTOMIZED PATIENT. Am J Trop Med Hyg
71: 53-55
[Abstract]
[Full Text]
-
Rolain, J. M., Brouqui, P., Koehler, J. E., Maguina, C., Dolan, M. J., Raoult, D.
(2004). Recommendations for Treatment of Human Infections Caused by Bartonella Species. Antimicrob. Agents Chemother.
48: 1921-1933
[Full Text]
-
Minnick, M. F., Wilson, Z. R., Smitherman, L. S., Samuels, D. S.
(2003). gyrA Mutations in Ciprofloxacin-Resistant Bartonella bacilliformis Strains Obtained In Vitro. Antimicrob. Agents Chemother.
47: 383-386
[Abstract]
[Full Text]
-
Jacomo, V., Kelly, P. J., Raoult, D.
(2002). Natural History of Bartonella Infections (an Exception to Koch's Postulate). CVI
9: 8-18
[Full Text]
-
Maurin, M., Raoult, D.
(2001). Use of Aminoglycosides in Treatment of Infections Due to Intracellular Bacteria. Antimicrob. Agents Chemother.
45: 2977-2986
[Full Text]
-
Rolain, J.-M., Maurin, M., Bryskier, A., Raoult, D.
(2000). In Vitro Activities of Telithromycin (HMR 3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis. Antimicrob. Agents Chemother.
44: 1391-1393
[Abstract]
[Full Text]